Neurocrine Biosciences, Inc. (FRA:NB3)

Neurocrine Biosciences Employees

Neurocrine Biosciences had 1,800 employees as of September 30, 2025. The number of employees increased by 100 or 5.88% compared to the same quarter last year.

• Employees: 1,800
• Change: 100
• Growth: 5.88%
• Revenue / Employee: €1,270,258
• Profits / Employee: €202,658
• Market Cap: 11.42B

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Sep 30, 2025	1,800	100	5.88%
Jun 30, 2025	1,800	300	20.00%
Mar 31, 2025	1,800	352	24.31%
Dec 31, 2024	1,800	400	28.57%
Sep 30, 2024	1,700	300	21.43%
Jun 30, 2024	1,500	150	11.11%
Mar 31, 2024	1,448	148	11.38%
Dec 31, 2023	1,400	200	16.67%
Sep 30, 2023	1,400	250	21.74%
Jun 30, 2023	1,350	250	22.73%
Mar 31, 2023	1,300	200	18.18%
Dec 31, 2022	1,200	300	33.33%
Sep 30, 2022	1,150	233	25.41%
Jun 30, 2022	1,100	216	24.43%
Mar 31, 2022	1,100	235	27.17%
Dec 31, 2021	900	55	6.51%
Sep 30, 2021	917	92	11.15%
Jun 30, 2021	884	104	13.33%
Mar 31, 2021	865	115	15.33%